Skip to main content
Pamela Becker, MD, Hematology, Bradbury, CA, City of Hope Comprehensive Cancer Center

PamelaSueBeckerMDPhD(She/Her)

Hematology Bradbury, CA

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Professor

Telehealth Available

Overview of Dr. Becker

Pamela S. Becker, MD, PhD is a physician scientist at City of Hope in the Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation.
Her research studies include the mechanism of cell adhesion-mediated chemotherapy resistance in AML, hematopoietic stem cell gene therapy for an inherited disorder of DNA repair, and precision therapy for AML, multiple myeloma, CML and all hematologic malignancies based on high-throughput drug sensitivity testing including correlation of mutations and gene expression with drug sensitivity.
Becker earned a medical degree and PhD at Harvard Medical School in the Harvard-MIT Health Sciences and Technology Program in Boston. She completed an internal medicine internship and residency at Beth Israel Hospital/Harvard Medical School in Boston and a fellowship in hematology at Yale University School of Medicine.
She has a long career as a translational researcher and is an author on over 200 peer-reviewed and other publications in the fields of inherited blood disorders, hematologic malignancies, and hematopoietic cell transplantation.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1991
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1986 - 1988
  • Harvard Medical School
    Harvard Medical SchoolClass of 1986

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2019 - 2025
  • WA State Medical License
    WA State Medical License 2003 - 2024
  • MA State Medical License
    MA State Medical License 1993 - 2005
  • CT State Medical License
    CT State Medical License 1988 - 2003
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase 1/2 Trial of Cladribine, High-Dose Cytarabine, Mitoxantrone, and G-CSF with Dose-Escalated Mitoxantrone for relapsed/refractory Acute Myeloid Leukemia or Other H...  
    Kelda M Gardner, Vivian G Oehler, Heather A Smith, Anna B Halpern, Paul C Hendrie, Sarah A Buckley, Roland B Walter, Pamela S Becker, Ryan D Cassaday, Asma Anwar, Bart..., Haematologica
  • Long Term Follow-up of Tandem Autologous-Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma  
    Parameswaran Hari, Brenda M Sandmaier, Pamela S Becker, Leona Holmberg, Damian J Green, Peter A McSweeney, David G Maloney, Thomas R Chauncey, Haematologica
  • Novel Lineage Depletion Preserves Autologous Blood Stem Cells for Gene Therapy of Fanconi Anemia Complementation Group A  
    Lauri M Burroughs, Pamela S Becker, Haematologica

Abstracts/Posters

  • Outcomes after Stem Cell Transplant in Older Patients with Acute Myeloid Leukemia Treated with Venetoclax-Based TherapiesClinically Relevant Abstract
    Pamela S. Becker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Frequency, and Effect on Survival, of Ineligibility for Clinical Trials in Newly Diagnosed Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
    Pamela S. Becker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Treatment of Refractory Acute Myeloid Leukemia and High-Grade Myelodysplastic Syndrome: Implications of Further Care at an Academic Center Versus Community Setting
    Pamela S. Becker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • A Multi-Omic Precision Medicine Clinical Trial in Acute Leukemia 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Machine Learning in Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observati... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • BBI ‘Catalytic Collaboration’ Grant Leads to ‘Extraordinary’ Progress in Research for Directing Treatment of Multiple Myeloma Patients
    BBI ‘Catalytic Collaboration’ Grant Leads to ‘Extraordinary’ Progress in Research for Directing Treatment of Multiple Myeloma PatientsMay 28th, 2021

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Illinois Blue Advantage HMO
    BCBS Illinois BlueChoice Select
    BCBS Illinois HMO
    BCBS Illinois PPO
    BCBS North Carolina BlueOptions PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Health Care PPO Platinum
    Coventry Missouri - HMO/POS
    First Choice
    First Health PPO
    Great West PPO
    Health Alliance PPO
    HealthLink PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    ODS Network
    Premera BCBS Heritage & Heritage Plus 1
    Providence Health System Personal Option
    Regence Washington - Preferred Provider Network
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment